OTLKNasdaq United States
Market cap
$190.737 M
$1.02 +4.88%
Close of 7 Aug 2026
Revenue
$1.41M
#3470 by revenue
Earnings
-$62.4M
Loss-making
Shares outstanding
120,863,252
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Outlook Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.